Cleveland Clinic’s revenues increased to $8.4 billion in 2017, up from $8 billion in the year prior. The boost was partially attributable to a 7 percent year-over-year increase in patient visits.
In 2017, Cleveland Clinic’s expenses totaled $7.4 billion, up from $7.2 billion in 2016.
After factoring in nonoperating gains, the system recorded a net income of $1.2 billion in 2017, compared to $513.5 million in the year prior.
Cleveland Clinic President and CEO Tom Mihaljevic, MD, highlighted the system’s financial results in a recent State of the Clinic presentation. He said the system’s success is largely due to the hard work of his predecessor, Toby Cosgrove, MD.
“The achievements of 2017 reflect the legacy of Dr. Toby Cosgrove,” Dr. Mihaljevic said. “He served Cleveland Clinic for more than 40 years — as cardiac surgeon, department chair, and CEO and president. He transformed Cleveland Clinic in more ways than we can count. He leaves us well-positioned for future growth.”
More articles on healthcare finance:
CHS sees Q4 net loss widen to $2B
LifePoint slips to $27.5M net loss in Q4
35 hospital groups urge court to halt $1.6B in Medicare payment cuts
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
